<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PAPER
  SYSTEM "paper-structure-annotation.dtd">
<PAPER><mode2 name="b311254c" hasDoc="yes" version="1085"/><TITLE><s sid="1"><CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/><text>Translocation of bioactive peptides across cell membranes by carbon nanotubes</text></s></TITLE><ABSTRACT><s sid="2"><CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/><text>Functionalised carbon nanotubes are able to cross the cell membrane and to accumulate in the cytoplasm or reach the nucleus without being toxic for the cell up to 10 µM.</text></s></ABSTRACT><BODY><DIV DEPTH="1"><HEADER/><P><s sid="3"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/><text>Biological applications of carbon nanotubes (CNTs) have started to emerge.<REF ID="R-0" REFID="cit2a"/><REF ID="R-1" REFID="cit2b"/><REF ID="R-2" REFID="cit3a"/><REF ID="R-3" REFID="cit3b"/><REF ID="R-4" REFID="cit4"/><REF ID="R-5" REFID="cit5a"/><REF ID="R-6" REFID="cit5b"/><REF ID="R-7" REFID="cit5c"/></text></s> <s sid="4"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/><text>This opening has been favored by the development of novel methods of solubilisation either by covalent or supramolecular functionalisation.<REF ID="R-8" REFID="cit3a"/><REF ID="R-9" REFID="cit3b"/><REF ID="R-10" REFID="cit4"/><REF ID="R-11" REFID="cit5a"/><REF ID="R-12" REFID="cit5b"/><REF ID="R-13" REFID="cit5c"/><REF ID="R-14" REFID="cit6a"/><REF ID="R-15" REFID="cit6b"/></text></s> <s sid="5"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/><text>Within the covalent strategy, the organic functionalisation of single- and multi-walled carbon nanotubes (SWNTs, MWNTs) by 1,3-dipolar cycloaddition of azomethine ylides can produce highly water soluble derivatives, ready for further modifications.<REF ID="R-16" REFID="cit7"/><REF ID="R-17" REFID="cit8"/></text></s> <s sid="6"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/><text>We have recently demonstrated that it is possible to prepare amino acid and peptide functionalised CNTs.<REF ID="R-18" REFID="cit1a"/><REF ID="R-19" REFID="cit1b"/><REF ID="R-20" REFID="cit1c"/><REF ID="R-21" REFID="cit8"/></text></s> <s sid="7"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/><text>In particular, peptide–SWNT conjugates elicit strong anti-peptide antibody responses in mice with no detectable cross-reactivity to the carbon nanotube.<REF ID="R-22" REFID="cit1b"/></text></s> <s sid="8"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="New" advantage="None"/><text>In this study we demonstrate that water soluble SWNT derivatives, modified with a fluorescent probe, translocate across cell membranes.</text></s> <s sid="9"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj2" novelty="New" advantage="None"/><text>We also show that a peptide responsible for the G protein function, when covalently linked to SWNTs, penetrates into the cell.<REF ID="R-23" REFID="cit9"/></text></s> <s sid="10"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>G proteins are an important family of proteins involved in signal transduction.</text></s> <s sid="11"><CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/><text>Since the functionalised CNTs appear to be non toxic for the cells (vide infra), they can be considered as a new tool to deliver peptides, peptidomimetics, or small organic molecules into the cells.</text></s> <s sid="12"><CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/><text>Therefore, these systems can help to solve transport problems for pharmacologically relevant compounds that need to be internalised, and may have potential therapeutic applications including vaccine delivery.<REF ID="R-24" REFID="cit1b"/><REF ID="R-25" REFID="cit10a"/><REF ID="R-26" REFID="cit10b"/><REF ID="R-27" REFID="cit10c"/><REF ID="R-28" REFID="cit11"/></text></s></P><P><s sid="13"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>To determine whether CNTs can be used to deliver active molecules into the cell, we have prepared the FITC-labeled single-walled carbon nanotube derivative 1 and the peptide–SWNT conjugate 2 (FITC, fluorescein isothiocyanate).</text></s></P><P><s sid="14"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>The SWNTs, characterised by a diameter of about 1 nm and a length in the range 300–1000 nm, were functionalised as previously described in order to obtain wires with free amino groups uniformly distributed around their side-walls.<REF ID="R-29" REFID="cit8"/></text></s> <s sid="15"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/><text>The amount of NH2 (loading) was 0.45 mmol per gram of CNT.</text></s> <s sid="16"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="New" advantage="None"/><text>CNT derivative 1 was easily prepared by mixing amino-modified SWNTs with FITC in dimethylformamide (see ESI).</text></s> <s sid="17"><CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="New" advantage="None"/><text>For the conjugation of the peptide onto CNTs we have used selective chemical ligation.<REF ID="R-30" REFID="cit1a"/></text></s> <s sid="18"><CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="New" advantage="None"/><text>We have chosen the peptide from the α subunit (αs) of the Gs protein corresponding to the amino acid sequence 384–394.</text></s> <s sid="19"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/><text>This peptide was shown to block β-adrenergic activation of adenyl cyclase in permeable cells and to mimic the effect of Gs to increase agonist affinity for the β-adrenergic receptor.<REF ID="R-31" REFID="cit9"/></text></s> <s sid="20"><CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="New" advantage="Yes"/><text>The peptide sequence corresponds to K(FITC)QRMHLRQYELLC, which is characterized by the insertion of a cysteine at the C-terminus for the conjugation to the maleimido group of the wires and the N-terminal fluorescence moiety coupled to the side chain of a lysine.</text></s> <s sid="21"><CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="New" advantage="None"/><text>The peptide was dissolved in water and coupled to the functionalized CNTs thus giving the peptide–SWNT 2 (see ESI).</text></s> <s sid="22"><CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="New" advantage="Yes"/><text>Both CNTs 1 and 2 are very soluble in water and at the high dilution required for the biological tests (vide infra) they do not aggregate.</text></s></P><P><s sid="23"><CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="New" advantage="None"/><text>CNTs 1 and 2 were examined by transmission electron microscopy (TEM).</text></s> <s sid="24"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/><text>Upon evaporation of the solvent, the tubes cluster into bundles of different diameters (see ESI).</text></s></P><P><s sid="25"><CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="New" advantage="None"/><text>The capacity of the fluorescent-labeled CNTs 1 and 2 to penetrate into the cells was studied by epifluorescence and confocal microscopy.</text></s> <s sid="26"><CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="New" advantage="None"/><text>Human 3T6 and murine 3T3 fibroblasts were cultured directly onto glass microscopy coverslips using RPMI 1640 medium at 37 °C until their monolayer confluence.</text></s> <s sid="27"><CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="New" advantage="None"/><text>FITC-carbon nanotubes 1 and 2 were added to the cells at room temperature and incubated at 37 °C for 60 min.</text></s> <s sid="28"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/><text>The concentration of fluorescein or peptide was 1, 5 and 10 µM, according to the amount of the amino functions.</text></s> <s sid="29"><CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="New" advantage="None"/><text>Subsequently, the cells were carefully rinsed with a buffer, fixed with paraformaldehyde, mounted on a microscope glass with an antifade agent and observed under the microscope.</text></s> <s sid="30"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/><text>Fig. 1 shows the epifluorescence and confocal microscopy images of the 3T3 and 3T6 cells treated with different concentrations of CNTs 1 and 2.</text></s> <s sid="31"><CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/><text>It is evident that 1 accumulates mainly in the cytoplasm.</text></s> <s sid="32"><CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/><text>Fluorescein alone and free FITC-peptide, used as controls, are not able to enter into the cells under the same experimental conditions.</text></s> <s sid="33"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs5" novelty="None" advantage="None"/><text>The confocal analysis (Fig. 1B) clearly shows the presence of the labeled compound inside the cell and not stuck outside the membrane.</text></s> <s sid="34"><CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/><text>Figures 1D and 1F show that peptide–carbon nanotube conjugate 2 is also able to cross the cell membranes, but in this case it distributes inside the nucleus, as evidenced by staining with DAPI (4′,6-diamidino-2-phenylindole) (Fig. 1C and 1E).</text></s> <s sid="35"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs6" novelty="None" advantage="None"/><text>The same translocation behaviour was observed for both derivatives using human keratinocytes.</text></s> <s sid="36"><CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/><text>The translocation pathway of the functionalised CNTs across the cell membrane remains to be elucidated.</text></s> <s sid="37"><CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/><text>It is clear that passive uptake mechanisms like endocytosis cannot be evoked for this process since the internalisation is not affected by temperature or the presence of endocytosis inhibitors.</text></s> <s sid="38"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs7" novelty="None" advantage="None"/><text>Indeed no difference in penetration capacity was observed between 37 and 4 °C, and treating the cells with sodium azide.</text></s> <s sid="39"><CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/><text>It seems that CNTs behave like cell penetrating peptides (CPPs) and related synthetic oligomers.<REF ID="R-32" REFID="cit12a"/><REF ID="R-33" REFID="cit12b"/><REF ID="R-34" REFID="cit12c"/><REF ID="R-35" REFID="cit12d"/><REF ID="R-36" REFID="cit12e"/><REF ID="R-37" REFID="cit12f"/></text></s> <s sid="40"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/><text>The cellular translocation mechanism of CPPs is still unclear.<REF ID="R-38" REFID="cit10a"/><REF ID="R-39" REFID="cit10b"/><REF ID="R-40" REFID="cit10c"/></text></s> <s sid="41"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/><text>Generally, these compounds are able to reach the cell nucleus, due to their cationic character and the presence of amino acid sequences responsible for the nuclear localisation signal.</text></s> <s sid="42"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/><text>Highly water soluble CNTs 1 and 2 do not contain these motifs.</text></s></P><P><s sid="43"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs8" novelty="None" advantage="None"/><text>However, while the destination of the former is cytoplasm, the peptide–SWNT derivative 2 goes mainly into the nucleus.</text></s> <s sid="44"><CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/><text>The reason for this different selectivity is still unknown and is under investigation.</text></s> <s sid="45"><CoreSc1 atype="GSC" type="Met" conceptID="Met7" novelty="New" advantage="None"/><text>We also analysed the fluorescence intensity at different times of incubation.</text></s> <s sid="46"><CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/><text>After 10 min the fluorescence was as intense as after 60 min, thus suggesting that saturation already occurs at short times.</text></s></P><P><s sid="47"><CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="New" advantage="None"/><text>In addition, the cytotoxicity caused by functionalised CNT 1 was studied by flow cytometry (FACS) in the range 1 to 10 µM concentration.<REF ID="R-41" REFID="cit13"/></text></s> <s sid="48"><CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="New" advantage="Yes"/><text>This technique allows observation of the health status of the cell population by staining the cells with different markers.</text></s> <s sid="49"><CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="New" advantage="None"/><text>Annexin V-APC (allophycocyanine) and propidium iodide were used as apoptotic and necrotic fluorescent probes, respectively.</text></s> <s sid="50"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/><text>Fig. 2 shows the cytofluorimetric analysis of 3T3 cells incubated with CNT 1 at 5 and 10 µM, respectively.</text></s></P><P><s sid="51"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/><text>Each red point corresponds to a single cell and its position on the graph represents the health status.</text></s> <s sid="52"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/><text>The lower-left quadrant corresponds to living cells, the lower- and upper-right quadrants correspond to apoptotic cells and the upper-left quadrant corresponds to necrotic cells.</text></s> <s sid="53"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/><text>When the fibroblasts were incubated with 5 µM of CNT 1, 90percent of the cell population remains alive (Fig. 2A).</text></s> <s sid="54"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/><text>In contrast, increasing twice the concentration of tubes induces 80percent of cell death (Fig. 2B).</text></s></P><P><s sid="55"><CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><text>In summary, we have demonstrated for the first time that functionalised CNTs are able to cross the cell membrane.</text></s> <s sid="56"><CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><text>From this study, it clearly appears that CNTs are a very promising carrier system for future applications in drug delivery and targeting therapy.</text></s> <s sid="57"><CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><text>For this purpose, we are currently exploring the use of CNTs as nanovehicles and evaluating the biological functions of the covalently linked molecules after cellular uptake.</text></s> <s sid="58"><CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><text>Finally, the absence of immunogenicity of the nanotubes,<REF ID="R-42" REFID="cit1b"/> in comparison to the common protein carriers, will increase the efficacy of the therapeutics delivered in this manner.</text></s></P><P><s sid="59"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/><text>This work was supported by CNRS, the University of Trieste and MIUR (cofin 2002, prot. 2002032171).</text></s> <s sid="60"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/><text>We are also grateful to S. Fournel and J. Mutterer for their help during flow cytometry and confocal microscopy measurements.</text></s></P></DIV></BODY></PAPER>